MY146805A - 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors - Google Patents

2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Info

Publication number
MY146805A
MY146805A MYPI20085209A MYPI20085209A MY146805A MY 146805 A MY146805 A MY 146805A MY PI20085209 A MYPI20085209 A MY PI20085209A MY PI20085209 A MYPI20085209 A MY PI20085209A MY 146805 A MY146805 A MY 146805A
Authority
MY
Malaysia
Prior art keywords
substituted
protease inhibitors
amino
benzothiazole sulfonamide
hiv protease
Prior art date
Application number
MYPI20085209A
Other languages
English (en)
Inventor
De Kock Herman Augustinus
Jonckers Tim Hugo Maria
Boonants Paul Jozef Gabriel Maria
Last Stefaan Julien
Dierynck Inge
Baumeister Judith Eva
T Klooster Gerben Albert Van Eleutherius
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of MY146805A publication Critical patent/MY146805A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MYPI20085209A 2006-06-23 2007-06-22 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors MY146805A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06116003 2006-06-23

Publications (1)

Publication Number Publication Date
MY146805A true MY146805A (en) 2012-09-28

Family

ID=37596252

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20085209A MY146805A (en) 2006-06-23 2007-06-22 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Country Status (30)

Country Link
US (1) US8202887B2 (enExample)
EP (1) EP2035432B1 (enExample)
JP (1) JP5232776B2 (enExample)
KR (1) KR101419320B1 (enExample)
CN (1) CN101479275B (enExample)
AP (1) AP2069A (enExample)
AR (1) AR061619A1 (enExample)
AT (1) ATE544769T1 (enExample)
AU (1) AU2007262943B2 (enExample)
BR (1) BRPI0713487B1 (enExample)
CA (1) CA2653233C (enExample)
CL (1) CL2007001826A1 (enExample)
CY (1) CY1112971T1 (enExample)
DK (1) DK2035432T3 (enExample)
EA (1) EA016387B1 (enExample)
ES (1) ES2381129T3 (enExample)
IL (1) IL195381A (enExample)
JO (1) JO2841B1 (enExample)
MX (1) MX2009000160A (enExample)
MY (1) MY146805A (enExample)
NZ (1) NZ573286A (enExample)
PE (1) PE20080342A1 (enExample)
PL (1) PL2035432T3 (enExample)
PT (1) PT2035432E (enExample)
SI (1) SI2035432T1 (enExample)
TW (1) TWI415851B (enExample)
UA (1) UA96445C2 (enExample)
UY (1) UY30416A1 (enExample)
WO (1) WO2007147884A1 (enExample)
ZA (1) ZA200810350B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3090B1 (ar) 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
PH12013500015A1 (en) 2010-07-02 2013-02-18 Gilead Sciences Inc 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
AP2013006706A0 (en) 2010-07-02 2013-02-28 Gilead Sciences Inc Napht-2-ylacetic acid derivatives to treat AIDS
US9024038B2 (en) * 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
UA111841C2 (uk) * 2011-04-21 2016-06-24 Гіліад Сайєнсіз, Інк. Сполуки бензотіазолу та їх фармацевтичне застосування
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
WO2013103738A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Napthalene acetic acid derivatives against hiv infection
US9096586B2 (en) 2012-04-20 2015-08-04 Gilead Sciences, Inc. Therapeutic compounds
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207862A (pt) * 2001-02-14 2004-06-22 Tibotec Pharm Ltd Inibidores de protease de hiv 2-(amino-substituìda)-benzotiazol-sulfonamida de amplo espectro
AR037797A1 (es) * 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
EP1545518A1 (en) * 2002-08-02 2005-06-29 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
ES2297467T3 (es) * 2003-09-30 2008-05-01 Tibotec Pharmaceuticals Ltd. Sulfonamidas de inhibicion de vhc.

Also Published As

Publication number Publication date
AP2008004679A0 (en) 2008-12-31
CA2653233C (en) 2015-09-29
AP2069A (en) 2009-12-08
CN101479275A (zh) 2009-07-08
BRPI0713487A2 (enExample) 2012-11-13
HK1125633A1 (en) 2009-08-14
CY1112971T1 (el) 2016-04-13
PT2035432E (pt) 2012-04-24
TW200817416A (en) 2008-04-16
SI2035432T1 (sl) 2012-06-29
CL2007001826A1 (es) 2008-01-18
CN101479275B (zh) 2012-03-07
US8202887B2 (en) 2012-06-19
ZA200810350B (en) 2010-05-26
ATE544769T1 (de) 2012-02-15
AU2007262943B2 (en) 2012-04-12
EP2035432B1 (en) 2012-02-08
IL195381A (en) 2013-01-31
UY30416A1 (es) 2008-01-31
AU2007262943A1 (en) 2007-12-27
AR061619A1 (es) 2008-09-10
WO2007147884A1 (en) 2007-12-27
BRPI0713487B1 (pt) 2022-07-26
PL2035432T3 (pl) 2012-07-31
BRPI0713487A8 (pt) 2018-01-02
EA200970052A1 (ru) 2009-04-28
PE20080342A1 (es) 2008-04-25
KR101419320B1 (ko) 2014-07-14
MX2009000160A (es) 2009-01-23
US20090209583A1 (en) 2009-08-20
JO2841B1 (en) 2014-09-15
DK2035432T3 (da) 2012-05-14
ES2381129T3 (es) 2012-05-23
UA96445C2 (ru) 2011-11-10
NZ573286A (en) 2011-09-30
EP2035432A1 (en) 2009-03-18
JP5232776B2 (ja) 2013-07-10
EA016387B1 (ru) 2012-04-30
IL195381A0 (en) 2009-08-03
CA2653233A1 (en) 2007-12-27
JP2009541272A (ja) 2009-11-26
TWI415851B (zh) 2013-11-21
KR20090024257A (ko) 2009-03-06

Similar Documents

Publication Publication Date Title
JO2841B1 (en) 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
MY155317A (en) Benzene sulfonamide thiazole and oxazole compounds
CR11618A (es) Inhibidores macrocíclicos de serina proteasa
BRPI0418639B8 (pt) compostos inibidores de dipeptidil peptidase, assim como composição farmacêutica contendo os mesmos
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
MX2009000884A (es) Derivados de piridizinona.
EA200870217A1 (ru) 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
MX2009009552A (es) Inhibidores de metaloproteasa que contienen una porcion heterociclica.
MA31918B1 (fr) Agents et épitopes de liaison à wise
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
MA33208B1 (fr) Anticorps anti-fgfr3 et procédés d'utilisation de ceux-ci
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
MX2009008925A (es) Compuestos de la formula (i) como inhibidores de proteasa de serina.
DE602007006051D1 (de) Präzisionsschleifbearbeitung von werkstückoberflächen
TW200740814A (en) Compounds
TW200736227A (en) New compounds III
UY30801A1 (es) Compuestos calciliticos
HN2006029142A (es) Proceso
MXPA04011466A (es) Inhibidores de la proteasa de hiv de benzisoxazol sulfonamida sustituida de amplio espectro.
TW200801015A (en) Substituted aminophenylsulfonamide compounds as HIV protease inhibitor
ATE491764T1 (de) Auto-adhäsiver klebstoff
DE602007005387D1 (de) Ptors
WO2006091861A8 (en) Compositions and methods relating to cns lymphoma
BRPI0414199A (pt) inibidores de entrada do vìrus hiv